Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 3,526–3,550 of 7,816 matching trials · page 142 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
engAGE: Managing cognitivE decliNe throuGh Theatre Therapy, Artificial Intelligence and Social Robots drivEn Interventions NCT06302686 engAGE system; Group practicing with only the support of a booklet Runs in: Italy; Norway; Switzerland · 3 sites |
NA other |
UNKNOWN | 78 | Istituto Nazionale di Ricovero e Cura per Anziani OTHER |
2024-03-12 |
|
Diagnostic Performance of Plasma Biomarkers of Alzheimer's Disease Compared With CSF Markers NCT06304129 Blood ponction Runs in: France · 1 site |
NA other |
UNKNOWN | 189 | Central Hospital, Nancy, France OTHER |
2024-03-12 |
|
HAAL: HeAlthy Ageing Eco-system for peopLe With Dementia NCT06307197 HAAL platform Runs in: Italy · 1 site |
NA other |
UNKNOWN | 10 | Istituto Nazionale di Ricovero e Cura per Anziani OTHER |
2024-03-12 |
|
Virtual Therapeutics for MCI NCT06079411 virtual reality non-embodied; virtual reality embodied; treatment as usual Runs in: Italy · 1 site |
NA other |
UNKNOWN | 36 | Istituto Auxologico Italiano OTHER |
2024-03-08 |
|
The Efficacy of VESPA 2.0 for Cognitive Rehabilitation in Patients With Mild Cognitive Impairment NCT06281314 Vespa software Runs in: Italy · 1 site |
NA other |
COMPLETED | 60 | IRCCS Centro Neurolesi Bonino Pulejo OTHER |
2024-03-08 |
|
A Study on Self-Compassion,Depression,and Quality of Life Among Primary Caregivers of People With Dementia NCT06301269 Runs in: Taiwan · 1 site |
NA other |
UNKNOWN | 160 | National Taiwan University Hospital OTHER |
2024-03-08 |
|
Montelukast Therapy on Alzheimer's Disease NCT03991988 Montelukast; Placebo oral tablet Runs in: United States · 4 sites |
PHASE2 anti-inflammatory |
COMPLETED | 32 | Emory University OTHER |
2024-03-07 |
|
Pathway to Detection & Differentiation of Delirium & Dementia in the Emergency Department NCT04846322 PD4ED 3-step intervention (ED assessment, outpatient assessment, Br... Runs in: United States · 2 sites |
NA other |
COMPLETED | 100 | Yale University OTHER |
2024-03-07 |
|
New CSF Biomarkers for Alzheimer's Disease NCT03621839 Runs in: France · 1 site |
NA other |
RECRUITING | 50,000 | Central Hospital, Nancy, France OTHER |
2024-03-06 |
|
Neural and Cognitive Correlates of Pragmatic Abilities NCT06297044 Neuropsychological assessment Runs in: Italy · 1 site |
NA other |
UNKNOWN | 324 | IRCCS San Camillo, Venezia, Italy OTHER |
2024-03-06 |
|
Study of the Effects of Adapted Tango and Multidimensional Intervention in pREvention of Dementia in agiNG (STRENGTH) NCT04146818 Adapted Tango Dancing; Control Runs in: Italy · 1 site |
NA other |
UNKNOWN | 300 | Istituto Nazionale di Ricovero e Cura per Anziani OTHER |
2024-03-05 |
|
The DURATION Study: reDUcing sedentaRy behAviour to Maintain cogniTIve functiON. NCT04323423 interrupting sedentary behaviour with light physical activity Runs in: Canada · 1 site |
NA other |
WITHDRAWN | 0 | Western University, Canada OTHER |
2024-03-05 |
|
Psycho-social Intervention With Paro Robotic Seal Focused on Patients With Dementia NCT05626205 PARO robot Runs in: Italy · 1 site |
NA other |
UNKNOWN | 20 | Istituto Nazionale di Ricovero e Cura per Anziani OTHER |
2024-03-05 |
|
Intermittent Oral-esophageal Tube Feeding in Alzheimer's Patients With Dysphagia NCT06220292 Conventional Care; Intermittent Oral-esophageal Tube Feeding; Nasog... Runs in: China · 1 site |
NA other |
WITHDRAWN | 0 | Zeng Changhao OTHER |
2024-03-05 |
|
REducing SEDENTary Behaviour May Slow Cognitive Decline in Older Adults With Mild Cognitive Impairment: A Pilot Study NCT03439059 Reducing Sedentary Behaviour Group Runs in: Canada · 1 site |
NA other |
COMPLETED | 21 | Western University, Canada OTHER |
2024-03-04 |
|
Brain Imaging in the Diabetes Prevention Program Outcomes Study NCT03757910 18F-MK-6240; 11C-PIB Runs in: United States · 1 site |
EARLY_PHASE1 other |
TERMINATED | 5 | José A. Luchsinger OTHER |
2024-03-04 |
|
Development and Validation of a Dementia Life Expectancy Tool NCT06266325 There is no intervention. Exposures are predictor variables of mortality. |
NA other |
COMPLETED | 202,217 | University of Toronto OTHER |
2024-03-04 |
|
The Effectiveness of TECH: Tablet Enhancement of Cognition and Health NCT02955277 TECH: Tablet Enhancement of Cognition and Health protocol; Standard... Runs in: Israel · 1 site |
NA other |
COMPLETED | 61 | Assuta Hospital Systems OTHER |
2024-03-01 |
|
Effects of a Robot on Physical and Psychosocial Outcomes of Persons With Dementia and Their Social Environment at Home NCT03818217 Coach Pepper group; Tablet group Runs in: Austria · 1 site |
NA other |
COMPLETED | 64 | Medical University of Graz OTHER |
2024-03-01 |
|
A Study to Evaluate ENT-01 for the Treatment of Parkinson's Disease Dementia NCT03938922 Active Investigational Treatment ENT-01 Runs in: United States · 3 sites |
PHASE1 other |
WITHDRAWN | 0 | Enterin Inc. INDUSTRY |
2024-03-01 |
|
Effect of Nordic Berries on Cognitive Function, Cardiometabolic Risk Markers and Gut Microbiota in Adults With Mild Cognitive Impairment NCT04317612 Active berry product; Reference product Runs in: Sweden · 2 sites |
NA other |
COMPLETED | 96 | Region Skane OTHER |
2024-03-01 |
|
Safety of SNK01 in Subjects With Alzheimer's Disease (ASK-AD) NCT04678453 SNK01 Runs in: Mexico · 1 site |
PHASE1 other |
TERMINATED | 10 | NKGen Biotech, Inc. INDUSTRY |
2024-03-01 |
|
KNA Proof-of-Concept NCT04968041 Motivational Interviewing-Cognitive Behavioral Therapy Ketogenic Nu... Runs in: United States · 1 site |
NA other |
COMPLETED | 10 | Florida State University OTHER |
2024-03-01 |
|
Pilot Study to Investigate the Effect of a Dysmenorrhoea App NCT06283225 Pia-App |
NA other |
UNKNOWN | 100 | Endo Health GmbH INDUSTRY |
2024-03-01 |
|
The Impact of 6-months of Resistance Training on Brain and Muscle Health in Older Adults With MCI NCT06252844 Resistance exercise training; Active control Runs in: Lithuania · 2 sites |
NA other |
UNKNOWN | 80 | Lithuanian Sports University OTHER |
2024-02-29 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial